{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:02:46Z","timestamp":1740106966487,"version":"3.37.3"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["156045"],"award-info":[{"award-number":["156045"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["USRA","USRA"],"award-info":[{"award-number":["USRA","USRA"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00213-020-05696-5","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T19:02:47Z","timestamp":1604516567000},"page":"475-486","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Nicotine-induced enhancement of a sensory reinforcer in adult rats: antagonist pretreatment effects"],"prefix":"10.1007","volume":"238","author":[{"given":"Doran J.","family":"Satanove","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. M. Vanessa","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suelynn","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2666-2072","authenticated-orcid":false,"given":"Paul B. S.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"5696_CR1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.bjp.0706048","volume":"144","author":"JG Baker","year":"2005","unstructured":"Baker JG (2005) The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Br J Pharmacol 144:317\u2013322","journal-title":"Br J Pharmacol"},{"key":"5696_CR2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1021\/jm020938y","volume":"46","author":"T Balle","year":"2003","unstructured":"Balle T, Perregaard J, Ramirez MT, Larsen AK, Soby KK, Liljefors T, Andersen K (2003) Synthesis and structure-affinity relationship investigations of 5-heteroaryl-substituted analogues of the antipsychotic sertindole. A new class of highly selective alpha(1) adrenoceptor antagonists. J Med Chem 46:265\u2013283","journal-title":"J Med Chem"},{"key":"5696_CR3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00213-016-4448-x","volume":"234","author":"ST Barrett","year":"2016","unstructured":"Barrett ST, Geary TN, Steiner AN, Bevins RA (2016) Sex differences and the role of dopamine receptors in the reward-enhancing effects of nicotine and bupropion. Psychopharmacology 234:187\u2013198","journal-title":"Psychopharmacology"},{"key":"5696_CR4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/FBP.0000000000000404","volume":"29","author":"ST Barrett","year":"2018","unstructured":"Barrett ST, Geary TN, Steiner AN, Bevins RA (2018) A behavioral economic analysis of the value-enhancing effects of nicotine and varenicline and the role of nicotinic acetylcholine receptors in male and female rats. Behav Pharmacol 29:493\u2013502","journal-title":"Behav Pharmacol"},{"key":"5696_CR5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00213-002-1156-5","volume":"163","author":"AR Caggiula","year":"2002","unstructured":"Caggiula AR, Donny EC, White AR, Chaudhri N, Booth S, Gharib MA, Hoffman A, Perkins KA, Sved AF (2002) Environmental stimuli promote the acquisition of nicotine self-administration in rats. Psychopharmacology 163:230\u2013237","journal-title":"Psychopharmacology"},{"key":"5696_CR6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1476-5381.1994.tb14748.x","volume":"111","author":"PBS Clarke","year":"1994","unstructured":"Clarke PBS, Chaudieu I, El-Bizri H, Boksa P, Quik M, Esplin BA, Capek R (1994) The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion. Br J Pharmacol 111:397\u2013405","journal-title":"Br J Pharmacol"},{"key":"5696_CR7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00432037","volume":"84","author":"PBS Clarke","year":"1984","unstructured":"Clarke PBS, Kumar R (1984) Effects of nicotine and d-amphetamine on intracranial self-stimulation in a shuttle box test in rats. Psychopharmacology 84:109\u2013114","journal-title":"Psychopharmacology"},{"key":"5696_CR8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00008877-200209000-00018","volume":"13","author":"C Cohen","year":"2002","unstructured":"Cohen C, Perrault G, Voltz C, Steinberg R, Soubrie P (2002) SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol 13:451\u2013463","journal-title":"Behav Pharmacol"},{"key":"5696_CR9","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00213-017-4778-3","volume":"235","author":"A Constantin","year":"2018","unstructured":"Constantin A, Clarke PBS (2018) Reinforcement enhancement by nicotine in adult rats: behavioral selectivity and relation to mode of delivery and blood nicotine levels. Psychopharmacology 235:641\u2013650","journal-title":"Psychopharmacology"},{"key":"5696_CR10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02431529","volume":"96","author":"WA Corrigall","year":"1988","unstructured":"Corrigall WA, Herling S, Coen KM (1988) Evidence for opioid mechanisms in the behavioral effects of nicotine. Psychopharmacology 96:29\u201335","journal-title":"Psychopharmacology"},{"key":"5696_CR11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejphar.2003.10.012","volume":"483","author":"J De Vry","year":"2004","unstructured":"De Vry J, Schreiber R, Eckel G, Jentzsch KR (2004) Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist\/inverse agonist SR141716A. Eur J Pharmacol 483:55\u201363","journal-title":"Eur J Pharmacol"},{"key":"5696_CR12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s002130100804","volume":"157","author":"V Deroche-Gamonet","year":"2001","unstructured":"Deroche-Gamonet V, Le MM, Piazza PV, Soubrie P (2001) SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats. Psychopharmacology 157:254\u2013259","journal-title":"Psychopharmacology"},{"key":"5696_CR13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00213-003-1473-3","volume":"169","author":"EC Donny","year":"2003","unstructured":"Donny EC, Chaudhri N, Caggiula AR, Evans-Martin FF, Booth S, Gharib MA, Clements LA, Sved AF (2003) Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement. Psychopharmacology 169:68\u201376","journal-title":"Psychopharmacology"},{"key":"5696_CR14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pbb.2003.09.017","volume":"77","author":"AM Epstein","year":"2004","unstructured":"Epstein AM, King AC (2004) Naltrexone attenuates acute cigarette smoking behavior. Pharmacol Biochem Behav 77:29\u201337","journal-title":"Pharmacol Biochem Behav"},{"key":"5696_CR15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00213-009-1569-5","volume":"205","author":"B Forget","year":"2009","unstructured":"Forget B, Coen KM, Le FB (2009) Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration--comparison with CB(1) receptor blockade. Psychopharmacology 205:613\u2013624","journal-title":"Psychopharmacology"},{"key":"5696_CR16","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/npp.2010.42","volume":"35","author":"B Forget","year":"2010","unstructured":"Forget B, Wertheim C, Mascia P, Pushparaj A, Goldberg SR, Le Foll B (2010) Noradrenergic alpha(1) receptors as a novel target for the treatment of nicotine addiction. Neuropsychopharmacology 35:1751\u20131760","journal-title":"Neuropsychopharmacology"},{"key":"5696_CR17","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1038\/sj.npp.1301545","volume":"33","author":"HG Fulton","year":"2008","unstructured":"Fulton HG, Barrett SP (2008) A demonstration of intravenous nicotine self-administration in humans? Neuropsychopharmacology 33:2042\u20132043","journal-title":"Neuropsychopharmacology"},{"key":"5696_CR18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/FBP.0000000000000092","volume":"25","author":"EG Guy","year":"2014","unstructured":"Guy EG, Fisher DC, Higgins GA, Fletcher PJ (2014) Examination of the effects of varenicline, bupropion, lorcaserin, or naltrexone on responding for conditioned reinforcement in nicotine-exposed rats. Behav Pharmacol 25:775\u2013783","journal-title":"Behav Pharmacol"},{"key":"5696_CR19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00213-012-2832-8","volume":"225","author":"EG Guy","year":"2013","unstructured":"Guy EG, Fletcher PJ (2013) Nicotine-induced enhancement of responding for conditioned reinforcement in rats: role of prior nicotine exposure and alpha4beta2 nicotinic receptors. Psychopharmacology 225:429\u2013440","journal-title":"Psychopharmacology"},{"key":"5696_CR20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pbb.2014.08.006","volume":"125","author":"EG Guy","year":"2014","unstructured":"Guy EG, Fletcher PJ (2014) Responding for a conditioned reinforcer, and its enhancement by nicotine, is blocked by dopamine receptor antagonists and a 5-HT receptor agonist but not by a 5-HT receptor antagonist. Pharmacol Biochem Behav 125:40\u201347","journal-title":"Pharmacol Biochem Behav"},{"key":"5696_CR21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0893-133X(95)00089-V","volume":"14","author":"GC Harris","year":"1996","unstructured":"Harris GC, Hedaya MA, Pan WJ, Kalivas P (1996) Beta-adrenergic antagonism alters the behavioral and neurochemical responses to cocaine. Neuropsychopharmacology 14:195\u2013204","journal-title":"Neuropsychopharmacology"},{"key":"5696_CR22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00213-001-0953-6","volume":"160","author":"AA Harrison","year":"2002","unstructured":"Harrison AA, Gasparini F, Markou A (2002) Nicotine potentiation of brain stimulation reward reversed by DHbetaE and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats. Psychopharmacology 160:56\u201366","journal-title":"Psychopharmacology"},{"key":"5696_CR23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0091-3057(92)90223-3","volume":"41","author":"D Huston-Lyons","year":"1992","unstructured":"Huston-Lyons D, Kornetsky C (1992) Effects of nicotine on the threshold for rewarding brain stimulation in rats. Pharmacol Biochem Behav 41:755\u2013759","journal-title":"Pharmacol Biochem Behav"},{"key":"5696_CR24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00213-010-1845-4","volume":"210","author":"N Ismayilova","year":"2010","unstructured":"Ismayilova N, Shoaib M (2010) Alteration of intravenous nicotine self-administration by opioid receptor agonist and antagonists in rats. Psychopharmacology 210:211\u2013220","journal-title":"Psychopharmacology"},{"key":"5696_CR25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s002130050441","volume":"134","author":"S Ivanov\u00e1","year":"1997","unstructured":"Ivanov\u00e1 S, Greenshaw AJ (1997) Nicotine-induced decreases in VTA electrical self-stimulation thresholds: blockade by haloperidol and mecamylamine but not scopolamine or ondansetron. Psychopharmacology 134:187\u2013192","journal-title":"Psychopharmacology"},{"key":"5696_CR26","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1038\/npp.2015.373","volume":"41","author":"KP Jensen","year":"2016","unstructured":"Jensen KP, DeVito E, Valentine G, Gueorguieva R, Sofuoglu M (2016) IV nicotine self-administration in smokers: dose-response function and sex differences. Neuropsychopharmacology 41:2034\u20132040","journal-title":"Neuropsychopharmacology"},{"key":"5696_CR27","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00213-014-3792-y","volume":"232","author":"A Kirshenbaum","year":"2014","unstructured":"Kirshenbaum A, Green J, Fay M, Parks A, Phillips J, Stone J, Roy T (2014) Reinforcer devaluation as a consequence of acute nicotine exposure and withdrawal. Psychopharmacology 232:1583\u20131594","journal-title":"Psychopharmacology"},{"key":"5696_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2016.08.003","volume":"150-151","author":"AP Kirshenbaum","year":"2016","unstructured":"Kirshenbaum AP, Suhaka JA, Phillips JL, de Souza Pinto MV (2016) Nicotine enhancement and reinforcer devaluation: interaction with opioid receptors. Pharmacol Biochem Behav 150-151:1\u20137","journal-title":"Pharmacol Biochem Behav"},{"key":"5696_CR29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/ntr\/ntr213","volume":"14","author":"ME Levin","year":"2012","unstructured":"Levin ME, Weaver MT, Palmatier MI, Caggiula AR, Sved AF, Donny EC (2012) Varenicline dose dependently enhances responding for nonpharmacological reinforcers and attenuates the reinforcement-enhancing effects of nicotine. Nicotine Tob Res 14:299\u2013305","journal-title":"Nicotine Tob Res"},{"key":"5696_CR30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00213-007-0863-3","volume":"194","author":"X Liu","year":"2007","unstructured":"Liu X, Palmatier MI, Caggiula AR, Donny EC, Sved AF (2007) Reinforcement enhancing effect of nicotine and its attenuation by nicotinic antagonists in rats. Psychopharmacology 194:463\u2013473","journal-title":"Psychopharmacology"},{"key":"5696_CR31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0091-3057(83)90243-5","volume":"18","author":"R Morgenstern","year":"1983","unstructured":"Morgenstern R, Fink H, Oelssner W (1983) LSD-potentiated apomorphine hypermotility: a model for differentiating antipsychotic drugs. Pharmacol Biochem Behav 18:13\u201317","journal-title":"Pharmacol Biochem Behav"},{"key":"5696_CR32","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.2174\/1568026619666190708164841","volume":"19","author":"T Nguyen","year":"2019","unstructured":"Nguyen T, Thomas BF, Zhang Y (2019) Overcoming the psychiatric side effects of the cannabinoid CB1 receptor antagonists: current approaches for therapeutics development. Curr Top Med Chem 19:1418\u20131435","journal-title":"Curr Top Med Chem"},{"key":"5696_CR33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1748-1716.1988.tb08384.x","volume":"133","author":"SO Ogren","year":"1988","unstructured":"Ogren SO, Fuxe K (1988) Apomorphine and pergolide induce hypothermia by stimulation of dopamine D-2 receptors. Acta Physiol Scand 133:91\u201395","journal-title":"Acta Physiol Scand"},{"key":"5696_CR34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00179179","volume":"90","author":"SO Ogren","year":"1986","unstructured":"Ogren SO, Hall H, Kohler C, Magnusson O, Sjostrand SE (1986) The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions. Psychopharmacology 90:287\u2013294","journal-title":"Psychopharmacology"},{"key":"5696_CR35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00213-003-1575-y","volume":"171","author":"P Olausson","year":"2004","unstructured":"Olausson P, Jentsch JD, Taylor JR (2004) Nicotine enhances responding with conditioned reinforcement. Psychopharmacology 171:173\u2013178","journal-title":"Psychopharmacology"},{"key":"5696_CR36","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1017\/S1461145706006560","volume":"9","author":"AC Pak","year":"2006","unstructured":"Pak AC, Ashby CR, Heidbreder CA, Pilla M, Gilbert J, Xi ZX, Gardner EL (2006) The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions. Int J Neuropsychopharmacol 9:585\u2013602","journal-title":"Int J Neuropsychopharmacol"},{"key":"5696_CR37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00213-005-0183-4","volume":"184","author":"MI Palmatier","year":"2006","unstructured":"Palmatier MI, Evans-Martin FF, Hoffman A, Caggiula AR, Chaudhri N, Donny EC, Liu X, Booth S, Gharib M, Craven L, Sved AF (2006) Dissociating the primary reinforcing and reinforcement-enhancing effects of nicotine using a rat self-administration paradigm with concurrently available drug and environmental reinforcers. Psychopharmacology 184:391\u2013400","journal-title":"Psychopharmacology"},{"key":"5696_CR38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pbb.2014.08.012","volume":"126","author":"MI Palmatier","year":"2014","unstructured":"Palmatier MI, Kellicut MR, Brianna SA, Brown RW, Robinson DL (2014) The incentive amplifying effects of nicotine are reduced by selective and non-selective dopamine antagonists in rats. Pharmacol Biochem Behav 126:50\u201362","journal-title":"Pharmacol Biochem Behav"},{"key":"5696_CR39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00213-009-1666-5","volume":"207","author":"MI Palmatier","year":"2009","unstructured":"Palmatier MI, Levin ME, Mays KL, Donny EC, Caggiula AR, Sved AF (2009) Bupropion and nicotine enhance responding for nondrug reinforcers via dissociable pharmacological mechanisms in rats. Psychopharmacology 207:381\u2013390","journal-title":"Psychopharmacology"},{"key":"5696_CR40","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1038\/sj.npp.1301623","volume":"33","author":"MI Palmatier","year":"2007","unstructured":"Palmatier MI, Liu X, Donny EC, Caggiula AR, Sved AF (2007) Metabotropic glutamate 5 receptor (mGluR5) antagonists decrease nicotine seeking, but do not affect the reinforcement enhancing effects of nicotine. Neuropsychopharmacology 33:2139\u20132147","journal-title":"Neuropsychopharmacology"},{"key":"5696_CR41","first-page":"646","volume":"297","author":"RL Papke","year":"2001","unstructured":"Papke RL, Sanberg PR, Shytle RD (2001) Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. J Pharmacol Exp Ther 297:646\u2013656","journal-title":"J Pharmacol Exp Ther"},{"key":"5696_CR42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/FBP.0b013e32832c7083","volume":"20","author":"NE Paterson","year":"2009","unstructured":"Paterson NE (2009) The neuropharmacological substrates of nicotine reward: reinforcing versus reinforcement-enhancing effects of nicotine. Behav Pharmacol 20:211\u2013225","journal-title":"Behav Pharmacol"},{"key":"5696_CR43","doi-asserted-by":"crossref","unstructured":"Perkins KA, Karelitz JL, Boldry MC (2017) Nicotine acutely enhances reinforcement from non-drug rewards in humans. Front Psychiatry 8: article 65","DOI":"10.3389\/fpsyt.2017.00065"},{"key":"5696_CR44","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1007\/s00213-018-4921-9","volume":"235","author":"H Rollema","year":"2018","unstructured":"Rollema H, Hurst RS (2018) The contribution of agonist and antagonist activities of alpha4beta2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data. Psychopharmacology 235:2479\u20132505","journal-title":"Psychopharmacology"},{"key":"5696_CR45","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1196\/annals.1441.019","volume":"1141","author":"JE Rose","year":"2008","unstructured":"Rose JE (2008) Disrupting nicotine reinforcement: from cigarette to brain. Ann N Y Acad Sci 1141:233\u2013256","journal-title":"Ann N Y Acad Sci"},{"key":"5696_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-010-1810-2","volume":"210","author":"JE Rose","year":"2010","unstructured":"Rose JE, Salley A, Behm FM, Bates JE, Westman EC (2010) Reinforcing effects of nicotine and non-nicotine components of cigarette smoke. Psychopharmacology 210:1\u201312","journal-title":"Psychopharmacology"},{"key":"5696_CR47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-3-319-13482-6_2","volume":"24","author":"LE Rupprecht","year":"2015","unstructured":"Rupprecht LE, Smith TT, Schassburger RL, Buffalari DM, Sved AF, Donny EC (2015) Behavioral mechanisms underlying nicotine reinforcement. Curr Top Behav Neurosci 24:19\u201353","journal-title":"Curr Top Behav Neurosci"},{"key":"5696_CR48","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0165-6147(94)90323-9","volume":"15","author":"P Seeman","year":"1994","unstructured":"Seeman P, Van Tol HHM (1994) Dopamine receptor pharmacology. Trends Pharmacol Sci 15:264\u2013270","journal-title":"Trends Pharmacol Sci"},{"key":"5696_CR49","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1124\/jpet.109.154641","volume":"330","author":"RE Sorge","year":"2009","unstructured":"Sorge RE, Clarke PB (2009) Rats self-administer intravenous nicotine delivered in a novel smoking-relevant procedure: effects of dopamine antagonists. J Pharmacol Exp Ther 330:633\u2013640","journal-title":"J Pharmacol Exp Ther"},{"key":"5696_CR50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-009-1647-8","volume":"207","author":"RE Sorge","year":"2009","unstructured":"Sorge RE, Pierre VJ, Clarke PB (2009) Facilitation of intravenous nicotine self-administration in rats by a motivationally neutral sensory stimulus. Psychopharmacology 207:191\u2013200","journal-title":"Psychopharmacology"},{"key":"5696_CR51","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuropharm.2009.04.006","volume":"57","author":"K Spiller","year":"2009","unstructured":"Spiller K, Xi ZX, Li X, Ashby CR Jr, Callahan PM, Tehim A, Gardner EL (2009) Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats. Neuropharmacology 57:60\u201366","journal-title":"Neuropharmacology"},{"key":"5696_CR52","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00213-012-2703-3","volume":"223","author":"KM Tobey","year":"2012","unstructured":"Tobey KM, Walentiny DM, Wiley JL, Carroll FI, Damaj MI, Azar MR, Koob GF, George O, Harris LS, Vann RE (2012) Effects of the specific \u03b14\u03b22 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice. Psychopharmacology 223:159\u2013168","journal-title":"Psychopharmacology"},{"key":"5696_CR53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0306-4522(92)90121-H","volume":"47","author":"F Trovero","year":"1992","unstructured":"Trovero F, Blanc G, Herve D, Vezina P, Glowinski J, Tassin JP (1992) Contribution of an alpha 1-adrenergic receptor subtype to the expression of the \u201cventral tegmental area syndrome\u201d. Neuroscience 47:69\u201376","journal-title":"Neuroscience"},{"key":"5696_CR54","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-4886(91)90001-S","volume":"111","author":"JK Wamsley","year":"1991","unstructured":"Wamsley JK, Hunt ME, McQuade RD, Alburges ME (1991) [3H]SCH39166, a D1 dopamine receptor antagonist: binding characteristics and localization. Exp Neurol 111:145\u2013151","journal-title":"Exp Neurol"},{"key":"5696_CR55","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1369-1600.2009.00203.x","volume":"15","author":"VC Wing","year":"2010","unstructured":"Wing VC, Shoaib M (2010) A second-order schedule of food reinforcement in rats to examine the role of CB1 receptors in the reinforcement-enhancing effects of nicotine. Addict Biol 15:380\u2013392","journal-title":"Addict Biol"},{"key":"5696_CR56","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/npp.2011.258","volume":"37","author":"JM Wright","year":"2012","unstructured":"Wright JM, Dobosiewicz MR, Clarke PB (2012) Alpha- and beta-adrenergic receptors differentially modulate the emission of spontaneous and amphetamine induced 50-kHz ultrasonic vocalizations in adult rats. Neuropsychopharmacology 37:808\u2013821","journal-title":"Neuropsychopharmacology"},{"key":"5696_CR57","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00213-017-4796-1","volume":"235","author":"JM Wright","year":"2018","unstructured":"Wright JM, Ren S, Constantin A, Clarke PBS (2018) Enhancement of a visual reinforcer by D-amphetamine and nicotine in adult rats: relation to habituation and food restriction. Psychopharmacology 235:803\u2013814","journal-title":"Psychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05696-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-020-05696-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05696-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T05:26:17Z","timestamp":1618205177000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-020-05696-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["5696"],"URL":"https:\/\/doi.org\/10.1007\/s00213-020-05696-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2020,11,4]]},"assertion":[{"value":"30 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All research procedures were reviewed and approved by the McGill Animal Care Committee in accordance with the guidelines of the Canadian Council on Animal Care.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}